4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001209191-23-055540
Director sold 10,000 shares at $3.71 ($37,100)
- Director acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Johnston John Joseph Director | 2023-11-14 | Option exercise 10b5-1 | +8,717 | $1.64 | $14,305 | 129,300 | D: show line 1 in the form |
| Johnston John Joseph Director | 2023-11-14 | Option exercise 10b5-1 | +1,283 | $2.14 | $2,748 | 130,583 | D: show line 2 in the form |
| Johnston John Joseph Director | 2023-11-14 | Sale 10b5-1 | −10,000 | $3.71 | $37,100 | 120,583 | D: show line 3 in the form |
| Open-market sales · 10,000 sh · avg $3.71 · $37,100 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Johnston John Joseph Director | 2023-11-14 | Option exercise · Stock Option (right to buy) 10b5-1 | −8,717 | 0 | D: show line 4 in the form | |||||
| Johnston John Joseph Director | 2023-11-14 | Option exercise · Stock Option (right to buy) 10b5-1 | −1,283 | 25,617 | D: show line 5 in the form |
Loading xslF345X05/doc4.xml…